Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.

@article{Utsunomiya2006AddedVO,
  title={Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT.},
  author={Daisuke Utsunomiya and Shinya Shiraishi and Masanori Imuta and Seiji Tomiguchi and Koichi Kawanaka and Shoji Morishita and Kazuo Awai and Yasuyuki Yamashita},
  journal={Radiology},
  year={2006},
  volume={238 1},
  pages={
          264-71
        }
}
PURPOSE To evaluate retrospectively if there is additional diagnostic value of fused single photon emission computed tomographic (SPECT) and computed tomographic (CT) images in assessing possible bone metastases. MATERIALS AND METHODS Institutional review board approval was obtained, and each patient provided written informed consent. Bone scintigraphy--including planar and SPECT imaging-and CT were performed with a combined SPECT/CT system in 45 oncologic patients (24 men, 21 women; mean age… 

Figures from this paper

The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

The addition of SPECT/CT resulted in a significant reduction of equivocal reports; a definitive diagnosis was given in the majority of the patients due to the improved diagnostic confidence compared to planar or SPECT imaging alone in prostate cancer patients with suspected bone metastases.

Should SPECT-CT replace SPECT for the evaluation of equivocal bone scan lesions in patients with underlying malignancies?

SPECT/CT significantly outperforms SPECT alone for the interpretation of skeletal lesions in patients undergoing bone scanning for metastases and is indicated in patients in whom correct classification of equivocal lesions is expected to alter the patient's management.

Is there Still Enough Diagnostic Confidence with Bone Spect Scintigraphy Alone: A Retrospective Evaluation and Extended Review of the Literature

SPECT without image fusion still gives sufficient diagnostic confidence for the differentiation of benign and malignant spine lesions, whereas continuous uptake patterns of the vertebral body and adjacent pedicle remain suspicious for malignancy.

Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history

IntroductionThree-phase bone scintigraphy using technetium-99m-methylene diphosphonate is used to diagnose skeletal lesions, whereas single-photon emission computed tomography/computed tomography

Single photon emission computed tomography/spiral computed tomography fusion imaging for the diagnosis of bone metastasis in patients with known cancer

SPECT/spiral CT is particularly valuable for the diagnosis of bone metastasis in patients with known cancer by providing precise anatomic localization and detailed morphologic characteristics.

Added value of SPECT/spiral CT versus SPECT in diagnosing solitary spinal lesions in patients with extraskeletal malignancies

Compared with SPECT imaging alone, SPECT/spiral CT imaging was more accurate and valuable in the differential diagnosis of solitary spinal lesions in patients with extraskeletal malignancies.

SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.

SPECT-guided CT was able to clarify more than 90% of SPECT findings classified as indeterminate in an analysis that was masked as to clinical pretest probability and the planar scan findings.

Added value of SPECT/CT in patients suspected of having bone infection: preliminary results

SPECT/CT improves the diagnostic performance of three-phase bone scan for osteomyelitis by avoiding false positive or equivocal results and is expectedly superior to X-ray in delivering the correct diagnosis.

Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.

Planar scintigraphy may suffice for differentiating benign and malignant lesions of the axial skeleton, but SPECT fused with CT significantly increases certainty in diagnosis and is the best tool for making a specific diagnosis.

Indeterminate lesions on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT-CT?

CT alone and SPECT-CT are better than SPECT for accurate characterisation of indeterminate lesions on planar BS in lung cancer patients and might be preferred because of shorter acquisition time and wider availability.
...

References

SHOWING 1-10 OF 38 REFERENCES

SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients.

SPECT-guided CT was able to clarify more than 90% of SPECT findings classified as indeterminate in an analysis that was masked as to clinical pretest probability and the planar scan findings.

Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.

Planar scintigraphy may suffice for differentiating benign and malignant lesions of the axial skeleton, but SPECT fused with CT significantly increases certainty in diagnosis and is the best tool for making a specific diagnosis.

Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG.

  • O. IsraelM. Mor A. Kuten
  • Medicine
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • 2002
A range of patterns presenting with or without abnormal (18)F-FDG uptake on camera-based PET and a mass on CT may occur in suspected cancer sites, which may provide new diagnostic opportunities in characterizing function and morphology in malignancies.

Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.

Skeletal metastases are one of the major clinical problems for the oncologist. Over the last several decades bone scintigraphy has been used extensively in detecting bone involvement since it can

The receiver operating characteristic curve for the standard uptake value in a group of patients with bone marrow metastasis.

Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?

It is concluded that side-by-side viewing of PET and CT scans is essential, as in 42.4% of all cases, combined viewing was important for a correct diagnosis in the series.

The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms.

TET enhances the already unique role of nuclear medicine procedures in the assessment and management of patients with endocrine neoplasms and alters prognosis in 2 patients with thyroid malignancy.

CT-SPECT fusion to correlate radiolabeled monoclonal antibody uptake with abdominal CT findings.

Fusion of computed tomography and SPECT images with radiolabeled, anti-carcinoembryonic antigen monoclonal antibody enabled identification of anatomic sites of tumor-specific MoAb accumulation in four cases, showed non- specific Mo Ab accumulation in two, and helped confirm information only suggested by the two studies separately in one.

Radionuclide bone imaging: an illustrative review.

Bone scintigraphy with technetium-99m-labeled diphosphonates is one of the most frequently performed of all radionuclide procedures and will likely remain a popular and important imaging modality for years to come.